Before surgery, a biopsy gene test could reveal which lung tumors are likely to recur

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon ...
Hosted on MSN

What Is a Liquid Biopsy for Lung Cancer?

A liquid biopsy is a blood test designed to detect cancer cells or DNA fragments of cancer cells circulating in the bloodstream. While a liquid biopsy may be useful for spotting several types of ...
KOAA News5

UCHealth Parkview utilizing new advanced robotic technology to detect lung cancer sooner

UCHealth Parkview has announced that it's expanding access to advanced lung diagnostics in southern Colorado with the Ion ...
EurekAlert!

Bronchoscopic lung-biopsy techniques match percutaneous approaches for comprehensive biomarker testing with fewer complications, new guideline concludes

(Denver, Colo.—July 14, 2025) -- A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP) and the Early Detection & Screening ...
Medscape

FDA OKs First Liquid Biopsy for Lung Cancer Mutation

The US Food and Drug Administration (FDA) today approved the first blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer ...

Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of an abstract at the European Lung Cancer Conference (ELCC) in Copenhagen, ...
ascopubs.org

Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non–Small Cell Lung Cancer (LIQUIK)

This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Morningstar

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Ultra-sensitive liquid biopsy is expanding precision medicine access for patients in Japan with treatment-resistant non-small cell lung cancer (NSCLC) MENLO PARK, Calif., Jan. 6, 2026 /PRNewswire/ -- ...
Healio

Navigational bronchoscopy similar to CT-guided biopsy in lung nodule diagnostic accuracy

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...